Company Filing History:
1 out of 2,168 
1 out of 81 
Years Active: 2022
Title: Hwa-Mi Lee: Innovator in Ischemia-Reperfusion Injury Treatment
Introduction
Hwa-Mi Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ischemia-reperfusion injury. His innovative work has led to the development of a unique composition that holds promise for medical applications.
Latest Patents
Hwa-Mi Lee holds 1 patent for his invention titled "Composition comprising extract for preventing or treating ischemia-reperfusion injury and use thereof." This patent provides a pharmaceutical composition that includes an extract as an active ingredient. The invention outlines a method for preventing or treating ischemia-reperfusion injury in a subject using either a food composition or the pharmaceutical composition.
Career Highlights
Throughout his career, Hwa-Mi Lee has been associated with prominent institutions such as the Korea Institute of Science and Technology and the University of Ulsan Foundation for Industry Cooperation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hwa-Mi Lee has collaborated with esteemed colleagues, including Chu Won Nho and Hak Cheol Kwon. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Hwa-Mi Lee's contributions to the treatment of ischemia-reperfusion injury through his patented composition highlight his role as an influential inventor in the pharmaceutical industry. His work continues to inspire advancements in medical research and treatment options.